- Home
- HRTX vs SY Comparison
HRTX vs SY Comparison
Compare HRTX & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRTX | SY |
|---|---|---|
| Founded | 1983 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.3M | 272.8M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HRTX | SY |
|---|---|---|
| Price | $0.39 | $1.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.50 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 4.1M | 903.2K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $15.28 | $38.64 |
| Revenue Next Year | $20.29 | $30.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.38 | $1.00 |
| 52 Week High | $2.30 | $6.28 |
Technical Indicators
Market Signals| Indicator | HRTX | SY |
|---|---|---|
| Relative Strength Index (RSI) | 23.14 | 27.65 |
| Support Level | N/A | N/A |
| Resistance Level | $1.34 | $3.34 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.83 | 0.00 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.